Cosmos price is down, but overselling might soon stir a trend reversal
a mixed twist to the growth of some less popular altcoins, the projection from Ali is evidence that Cosmos might have been oversold, leaving the possible pathway for the token a bullish, upward one.on a consistent push for the growth of its ecosystem. In a recent update shared by the protocol, it said that Cosmos Hub Governance has been far more alive than ever, with verifiable evidence to show over the past few months.
"Cosmos Hub Governance is more active than ever! In the last months we saw an increasing number of draft props and forum activity. This is the sign of a thriving decentralized community. It also enlights the need for a specialized channel for governance," the protocolIt further noted that its Governance Hub will play a key role in onboarding consumer chains that can drive increased adoption in the near future.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Raymond James says this sold-off solar stock could be due for a comebackThe firm's price target implies the share price could grow 22.5% in the next year.
Read more »
Canadian piece of Porsche history for sale for first timeThe one\u002Doff Spexter Porsche Speedster – which may or may not have inspired the Boxster – has a firm asking price of US$450,000
Read more »
Amazon might be making a browser to compete with ChromeYou may be familiar with Amazon as a store and streaming service, but soon you may hear about its browser too, as a survey suggests the company may be considering making one.
Read more »
Bank jitters aside, oil prices should recover this weekWest Texas Intermediate, the U.S. benchmark for the price of oil, hovered in the upper...
Read more »
Cardano (ADA) Price Analysis for March 19Can the growth of ADA continue next week? CardanoStiftung ADAcoin_ Cardano cardano Cardano_ emurgo_io CardanoCommunity
Read more »
The high price of Ozempic is pushing many to unregulated, copycat drugs for weight lossNovo Nordisk, the sole manufacturer of Ozempic and the patent-holder of semaglutide, said it does not provide the ingredient to pharmacies, leading some experts to question where pharmacies are sourcing the drug — and whether it is semaglutide at all.
Read more »